Leah Wright

Leah Wright

School of Chemical Engineering

Faculty of Sciences, Engineering and Technology

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.

  • Journals
    Year Citation
    2023 Wright, L., Wignall, A., Jõemetsa, S., Joyce, P., & Prestidge, C. A. (2023). A membrane-free microfluidic approach to mucus permeation for efficient differentiation of mucoadhesive and mucopermeating nanoparticulate systems. Drug Delivery and Translational Research, 13(4), 1088-1101.
    DOI Scopus4 Europe PMC3
    2022 Wright, L., Barnes, T. J., Joyce, P., & Prestidge, C. A. (2022). Optimisation of a High-Throughput Model for Mucus Permeation and Nanoparticle Discrimination Using Biosimilar Mucus. Pharmaceutics, 14(12), 2659.
    DOI Scopus2
    2022 Joyce, P., Wignall, A., Peressin, K., Wright, L., Williams, D. B., & Prestidge, C. A. (2022). Chitosan nanoparticles facilitate improved intestinal permeation and oral pharmacokinetics of the mast cell stabiliser cromoglycate. International Journal of Pharmaceutics, 612, 121382.
    DOI Scopus3 Europe PMC3
    2021 Wright, L., Joyce, P., Barnes, T. J., Lundmark, R., Bergström, C. A. S., Hubert, M., & Prestidge, C. A. (2021). A Comparison of Chitosan, Mesoporous Silica and Poly(lactic-co-glycolic) Acid Nanocarriers for Optimising Intestinal Uptake of Oral Protein Therapeutics. Journal of Pharmaceutical Sciences, 110(1), 217-227.
    DOI Scopus8 Europe PMC4
    2021 Wright, L., Joyce, P., Barnes, T. J., & Prestidge, C. A. (2021). Mimicking the Gastrointestinal Mucus Barrier: Laboratory-Based Approaches to Facilitate an Enhanced Understanding of Mucus Permeation. ACS Biomaterials Science & Engineering, 9(6), 19 pages.
    DOI Scopus11 Europe PMC1
    2020 Wright, L., Barnes, T. J., & Prestidge, C. A. (2020). Oral delivery of protein-based therapeutics: Gastroprotective strategies, physiological barriers and in vitro permeability prediction. International Journal of Pharmaceutics, 585, 119488-1-119488-17.
    DOI Scopus23 Europe PMC7
    2018 Wright, L., Rao, S., Thomas, N., Boulos, R. A., & Prestidge, C. A. (2018). Ramizol<sup>®</sup> encapsulation into extended release PLGA micro- and nanoparticle systems for subcutaneous and intramuscular administration: <i>in vitro</i> and <i>in vivo</i> evaluation. Drug Development and Industrial Pharmacy, 44(9), 1451-1457.
    DOI Scopus16 WoS12 Europe PMC7

  • Current Higher Degree by Research Supervision (University of Adelaide)
    Date Role Research Topic Program Degree Type Student Load Student Name
    2024 Co-Supervisor Design of Ready-to-Inject Aqueous Formulations of RNA-Lipid Nanoparticles Doctor of Philosophy Doctorate Full Time Ms Jaslene Anne Francis
    2024 Co-Supervisor Building Stability into RNA Lipid Nanoparticle Therapeutics and Vaccines Doctor of Philosophy Doctorate Full Time Mr Ziyue Li
    2024 Co-Supervisor In-vitro mRNA Transcription in Microfluidic Channels for use in RNA Therapeutics and Vaccines Doctor of Philosophy Doctorate Full Time Mr Chandranil Hridaynath Gharekhan
    2024 Co-Supervisor Disentangling the Complexity of mRNA Lipid Nanoparticle (mRNA-LNP) Assembly in Microfluidic Reactors Doctor of Philosophy Doctorate Full Time Ms Jessica Boutros
Connect With Me
External Profiles